Title: Design, synthesis, and docking of highly hypolipidemic agents: Schizosaccharomyces pombe as a new model for evaluating alpha-asarone-based HMG-CoA reductase inhibitors.
Journal: Bioorganic & medicinal chemistry 20100615
212775-06-9
7510-46-5
57637-97-5 | N-ACETYLAMINOMETHYLPHOSPHONATE | AA00EEG7 | MFCD14105617
566-03-0 | 5-B-PREGNANE-3-A-21-DIOL-11-20-DIONE | AA00EEL9 | MFCD00051127
62574-23-6 | 2-Methyl-3-(methylsulfanyl)propanoic acid | AA00EES0 | MFCD12823558
602-07-3 | 1-(2-(Dimethylamino)ethyl)-3,8-dimethoxychromeno[5,4,3-cde]chromene-5,10-dione | AA00EEYF | MFCD09837996
5840-76-6 | 3-Methyloxazolidine-2,5-dione | AA00EF45 | MFCD02684172
615568-49-5 | 2-Oxo-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazine-7-carboxylic acid | AA00EFAY | MFCD18260632
60633-78-5 | 2-(2-Bromoethoxy)benzenecarbaldehyde | AA00EFJM | MFCD00021055
58139-08-5 | 2-Iodo-3-methylpyrazine | AA00EFTM | MFCD08705768
59951-65-4 | 1-Bromo-4-phenylnaphthalene | AA00EG5R | MFCD17012346
63594-37-6 | H-Orn(z)-obzl hcl | AA00EGNX | MFCD00237210